| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 210 | 218 | −3.3% |
| EBITDA | 8.0 | 34.0 | −76.6% |
| EBITDA margin | 3.8% | 15.6% | −11.8 pts |
| Profit before tax | 30.1 | 48.3 | −37.7% |
| Net profit | 23.9 | 35.2 | −32.2% |
| EPS | ₹9.07 | ₹13.37 | −32.2% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,741 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 371 | 371 | 288 | 373 | 277 | ||
| 1,370 | — | — | — | — | ||
| 869 | 876 | 832 | 826 | 634 | ||
| — | +5.3% | +0.7% | +30.3% | — | ||
| 99.6 | 126 | 168 | 220 | 157 | ||
| 11.5% | 14.3% | 20.2% | 26.7% | 24.7% | ||
| 81.3 | 109 | 154 | 206 | 138 | ||
| 105 | 117 | 163 | 192 | 128 | ||
| 12.1% | 13.3% | 19.6% | 23.2% | 20.1% | ||
| ₹40.03 | ₹44.34 | ₹61.91 | ₹72.77 | ₹48.53 | ||
| — | −28.4% | −14.9% | +49.9% | — | ||
| — | 117 | 151 | 222 | 49.8 | ||
| — | −28.4 | −15.2 | −28.6 | −3.7 | ||
| 89.1 | 89.1 | 136 | 193 | 46.1 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 1,740.5 | |
| - Cash, Equiv & ST Investments | 276.8 | 373.4 | 287.5 | 371.0 | 371.0 | |
| Enterprise Value | — | — | — | — | 1,369.5 | |
| Revenue | 634.5 | 826.5 | 832.3 | 876.0 | 868.7 | |
| Growth %, YoY | — | +30.3 | +0.7 | +5.3 | — | |
| EBITDA | 156.8 | 220.4 | 168.4 | 125.6 | 99.6 | |
| Margin % | 24.71 | 26.67 | 20.23 | 14.33 | 11.46 | |
| EBIT | 138.0 | 205.9 | 153.5 | 109.1 | 81.3 | |
| Net Income | 127.8 | 191.6 | 163.0 | 116.7 | 105.4 | |
| Margin % | 20.14 | 23.18 | 19.59 | 13.33 | 12.13 | |
| EPS, Adj (current shares) | 48.53 | 72.77 | 61.91 | 44.34 | 40.03 | |
| Growth %, YoY | — | +49.9 | -14.9 | -28.4 | — | |
| Cash from Operations | 49.8 | 222.0 | 150.9 | 117.5 | — | |
| Capital Expenditures | -3.7 | -28.6 | -15.2 | -28.4 | — | |
| Free Cash Flow | 46.1 | 193.4 | 135.7 | 89.1 | 89.1 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Nucleus Software Exports (NSE: NUCLEUS) had a market capitalisation of ₹1,718 crore at the 30 October 2026 close (₹652.60 a share), a PE ratio of 16.3 on the last four quarters' profit and a price-to-book ratio of 1.89. In FY26 its consolidated net profit was ₹117 crore on revenue of ₹876 crore; in Q1 FY27 (April–June 2026) it was ₹23.9 crore, down 32.2% year on year. It had no borrowings on 31 March 2026. Promoters held 73.60% of the shares on 30 September 2026.
Nucleus Software Exports' PE ratio is 16.3 at the 30 October 2026 close (₹652.60 a share): a market capitalisation of ₹1,718 crore divided by consolidated net profit of ₹105 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹117 crore) it is 14.7.
Nucleus Software Exports' price-to-book (PB) ratio is 1.89 at the 30 October 2026 close: a market capitalisation of ₹1,718 crore divided by shareholders' equity (book value) of ₹907 crore on 31 March 2026. That is a book value of ₹344.64 per share against a share price of ₹652.60.
Nucleus Software Exports' book value per share was ₹344.64 on 31 March 2026: shareholders' equity of ₹907 crore divided by the 2.63 crore shares in issue, up 11.5% from ₹309.24 a year earlier. The share price at the 30 October 2026 close was ₹652.60.
Nucleus Software Exports' market capitalisation was ₹1,718 crore at the 30 October 2026 close: 2.63 crore shares at ₹652.60 each.
Yes. Nucleus Software Exports had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹414 crore of cash, bank balances and current investments.
Nucleus Software Exports' basic earnings per share (EPS) were ₹44.35 in FY26, against ₹61.40 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹40.04.
Nucleus Software Exports' debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹907 crore. A year earlier, on 31 March 2025, it was 0.00.
Nucleus Software Exports' dividend yield is 1.92% at the 30 October 2026 close: dividends of ₹12.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹652.60. They were ₹12.50 on 10 July 2026.
Promoters held 73.60% of Nucleus Software Exports on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Nucleus Software Exports' net worth — shareholders' equity in its consolidated balance sheet — was ₹907 crore on 31 March 2026, up 11.5% from ₹814 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,718 crore at the 30 October 2026 close.
In FY26, Nucleus Software Exports' return on equity (ROE) was 13.6% and its return on capital employed (ROCE) was 11.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 20.5% and ROCE 18.2%.
On 30 September 2026, Nucleus Software Exports' shares were held by promoters 73.60%, foreign portfolio investors (FII/FPI) 2.56%, domestic institutions (DII) 1.25% (including mutual funds at 0.84%) and retail and other non-institutional investors 22.16%. Over the year, FII holding was down 2.62 percentage points from 5.18% and DII holding was down 0.24 percentage points from 1.49%.
In 2026, Nucleus Software Exports has declared one dividend: ₹12.50 with record date 10 July 2026.
In FY26, Nucleus Software Exports generated ₹117 crore of cash from operations and spent ₹28.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹89.1 crore. In FY25 it was ₹136 crore.
Nucleus Software Exports will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, the date of the board meeting it has notified to the exchanges.
Nucleus Software Exports' latest results are for Q1 FY27 (April–June 2026), filed on 30 July 2026: consolidated net profit ₹23.9 crore, down 32.2% from ₹35.2 crore in Q1 FY26; revenue from operations ₹210 crore, down 3.3% year on year.
In FY26 (April 2025–March 2026), Nucleus Software Exports' consolidated net profit was ₹117 crore, down 28.4% from ₹163 crore in FY25, on revenue from operations of ₹876 crore (up 5.3%). Over three years, from FY23, net profit was down 8.6%.
At the 30 October 2026 closing prices, on FY26 net profit, Nucleus Software Exports' PE ratio is 14.7, the lowest of the four: Ramco Systems 45.6, Subex 32.2 and Unicommerce Esolutions 43.6, a peer average of 40.4. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Ramco Systems, Subex and Unicommerce Esolutions: Nucleus Software Exports' operating margin of 12.5% is the second highest of the four (Ramco Systems 9.6%, Subex 4.9%, Unicommerce Esolutions 12.5%; peer average 9.0%); its return on equity of 13.6% is the second highest of the four (Ramco Systems 12.6%, Subex 8.8%, Unicommerce Esolutions 15.6%; peer average 12.3%).
In FY26, Nucleus Software Exports earned net profit of ₹117 crore on revenue of ₹876 crore, against ₹41.8 crore on ₹701 crore for Ramco Systems. Nucleus Software Exports' operating margin was 12.5% (Ramco Systems 9.6%) and its return on equity 13.6% (Ramco Systems 12.6%). At the 30 October 2026 close, Nucleus Software Exports' market capitalisation was ₹1,718 crore against ₹1,906 crore for Ramco Systems, and its PE ratio on FY26 profit 14.7 against 45.6.
From Nucleus Software Exports' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.